The diagnostic accuracy of ctDNA analysis in detecting EGFR mutations in NSCLC patients’ plasma has been confirmed in several studies, where a high level of concordance compared to traditional tissue genotyping has been observed [40]. This evidence concerns the gene EGFR and non-small cell lung carcinoma.